Results 221 to 230 of about 289,315 (327)

Snap on Smile: Instant Smile

open access: yesJournal of Mahatma Gandhi University of Medical Sciences and Technology, 2018
Ashwini B Prasad   +5 more
openaire   +1 more source

Self‐completed patient‐reported outcome measures in adults with epilepsy: A review

open access: yesEpilepsia Open, EarlyView.
Abstract Epilepsy affects 65 million people worldwide, and is a World Health Organization priority disease as highlighted in their 2022–2031 Intersectoral Global Action Plan (IGAP) on Epilepsy and other Neurological Disorders. IGAP's objectives include improving epilepsy treatment and care.
Alison L. Conquest   +5 more
wiley   +1 more source

Stiripentol use in Dravet syndrome patients in the USA: Results of a real‐world study

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy with a high seizure burden and mortality risk. Stiripentol, one of the first DS‐specific therapies, received FDA approval in 2018 but its real‐world use and impact post‐approval in the USA remain insufficiently characterized.
Elaine Wirrell   +11 more
wiley   +1 more source

Cost‐effectiveness of fenfluramine as add‐on treatment in the management of Dravet Syndrome: A real‐world multicenter study

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Dravet syndrome (DS) is a rare disease with a high clinical and socioeconomic impact on patients, society, and the healthcare system. The recent approval of therapies such as fenfluramine (FFA) has transformed the treatment landscape; however, data on their cost‐effectiveness are still scarce. This study evaluates the real‐world cost‐
Paolo A. Cortesi   +15 more
wiley   +1 more source

Smile-related oral characteristics in vietnamese students. [PDF]

open access: yesActa Odontol Latinoam
Pham TAV, Le PP, Nguyen PA.
europepmc   +1 more source

Home - About - Disclaimer - Privacy